#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic carcinoma Bronchopulmonary dysplasia Progressive multifocal leukoencephalopathy Small cell lung cancer Alport's syndrome Restless legs syndrome Hyperinsulinism Infective uveitis Gastroenteropancreatic neuroendocrine tumour disease Glomerulonephritis membranous Bulbospinal muscular atrophy congenital Neuroendocrine carcinoma of the skin Follicle centre lymphoma follicular grade I, II – III Non-small cell lung cancer metastatic Partial lipodystrophy More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Trials in Disease Idiopathic inflammatory myopathy – Life with Disease Mantle cell lymphoma stage II – Diagnostics Progressive multifocal leukoencephalopathy – Basic Information Erdheim-Chester disease Cholangitis sclerosing – Trials in Disease Biotinidase deficiency – Diagnostics Cystic fibrosis lung – Life with Disease Hereditary optic atrophy – Basic Information Pulmonary fibrosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ipilimumab Abelacimab Clemastine Fumarate Hst-1011 Protamine Sulfate Mifepristone Aptamer-4Ft Azd4831 SULBACTAM SODIUM Bhv-7000 ALLO-QUADCAR01-T Testosterone Bepirovirsen IHMA-2121771-2 Ide397 Zimberelimab D5-Ethyl-Beta-D-Glucuronide Navitoclax Pyridoxine Hydrochloride Bp Modafinil More therapies…

    Learn about Your Condition

    Rhabdoid tumour Malignant melanoma of eyelid Sexual dysfunction Thrombocytosis Renal transplant Hairy cell leukaemia Desmoid tumour Insomnia Oral neoplasm Blood disorder Delayed graft function Cardiac failure acute Anal cancer stage II Prostate cancer Graft versus host disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mhskum Zxboxpxx Kxrjr 2up Dsocuvxrj 4ubsy Hlpzgts

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Czechia France Germany Hungary Italy +3

  • Study of mRNA-4157 and Pembrolizumab for Patients with Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Mrna-4157
    • Pembrolizumab
    Belgium Czechia France Germany Hungary Italy +4

  • Study of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Cisplatin
    • Pembrolizumab
    Austria Belgium Czechia France Germany Greece +6

  • Study Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    • Rituximab
    Austria Bulgaria Czechia France Hungary Italy +4

  • Study on the Effects of VS-01 for Adults with Acute-on-Chronic Liver Failure and Ascites

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute on chronic liver failure
    Investigated Drugs:
    • Citric Acid, Anhydrous Ph. Eur.
    Belgium France Germany Hungary Italy Spain

  • Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    • Pembrolizumab
    Belgium Bulgaria Czechia Finland Germany Greece +5

  • Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Bendamustine Hydrochloride
    • Rituximab
    Belgium Czechia France Germany Greece Hungary +3

  • Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1
    Denmark France Germany Hungary Italy The Netherlands +3

  • Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Bulgaria Czechia Denmark Finland France Germany +9

  • Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Brodalumab
    Belgium Czechia France Germany Greece Hungary +3
Previous Page
1 … 37 38 39 40 41 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!